ArticleCell reports. Medicine2024

Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma.

Oliver Van Oekelen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.